464 related articles for article (PubMed ID: 9840920)
1. A 5'-CG-3'-rich region in the promoter of the transcriptionally frequently silenced RET protooncogene lacks methylated cytidine residues.
Munnes M; Patrone G; Schmitz B; Romeo G; Doerfler W
Oncogene; 1998 Nov; 17(20):2573-83. PubMed ID: 9840920
[TBL] [Abstract][Full Text] [Related]
2. Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients.
Itoh F; Ishizaka Y; Tahira T; Yamamoto M; Miya A; Imai K; Yachi A; Takai S; Sugimura T; Nagao M
Oncogene; 1992 Jun; 7(6):1201-6. PubMed ID: 1350670
[TBL] [Abstract][Full Text] [Related]
3. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.
Attié T; Pelet A; Edery P; Eng C; Mulligan LM; Amiel J; Boutrand L; Beldjord C; Nihoul-Fékété C; Munnich A
Hum Mol Genet; 1995 Aug; 4(8):1381-6. PubMed ID: 7581377
[TBL] [Abstract][Full Text] [Related]
4. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X
J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
[TBL] [Abstract][Full Text] [Related]
6. Sequence and characterisation of the RET proto-oncogene 5' flanking region: analysis of retinoic acid responsiveness at the transcriptional level.
Patrone G; Puliti A; Bocciardi R; Ravazzolo R; Romeo G
FEBS Lett; 1997 Dec; 419(1):76-82. PubMed ID: 9426223
[TBL] [Abstract][Full Text] [Related]
7. Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease (HSCR).
Fitze G; Appelt H; König IR; Görgens H; Stein U; Walther W; Gossen M; Schreiber M; Ziegler A; Roesner D; Schackert HK
Hum Mol Genet; 2003 Dec; 12(24):3207-14. PubMed ID: 14600022
[TBL] [Abstract][Full Text] [Related]
8. Sp1 and Sp3 transactivate the RET proto-oncogene promoter.
Andrew SD; Delhanty PJ; Mulligan LM; Robinson BG
Gene; 2000 Oct; 256(1-2):283-91. PubMed ID: 11054558
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the promoter region and oligomerization domain of H4 (D10S170), a gene frequently rearranged with the ret proto-oncogene.
Tong Q; Li Y; Smanik PA; Fithian LJ; Xing S; Mazzaferri EL; Jhiang SM
Oncogene; 1995 May; 10(9):1781-7. PubMed ID: 7753554
[TBL] [Abstract][Full Text] [Related]
10. The physical map of the human RET proto-oncogene.
Pasini B; Hofstra RM; Yin L; Bocciardi R; Santamaria G; Grootscholten PM; Ceccherini I; Patrone G; Priolo M; Buys CH
Oncogene; 1995 Nov; 11(9):1737-43. PubMed ID: 7478601
[TBL] [Abstract][Full Text] [Related]
11. Localization of promoter elements in the human mu-opioid receptor gene and regulation by DNA methylation.
Andria ML; Simon EJ
Brain Res Mol Brain Res; 1999 Jun; 70(1):54-65. PubMed ID: 10381543
[TBL] [Abstract][Full Text] [Related]
12. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient.
Angrist M; Bolk S; Halushka M; Lapchak PA; Chakravarti A
Nat Genet; 1996 Nov; 14(3):341-4. PubMed ID: 8896568
[TBL] [Abstract][Full Text] [Related]
13. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems.
Hofstra RM; Wu Y; Stulp RP; Elfferich P; Osinga J; Maas SM; Siderius L; Brooks AS; vd Ende JJ; Heydendael VM; Severijnen RS; Bax KM; Meijers C; Buys CH
Hum Mutat; 2000; 15(5):418-29. PubMed ID: 10790203
[TBL] [Abstract][Full Text] [Related]
14. Familial form of hirschsprung disease: nucleotide sequence studies reveal point mutations in the RET proto-oncogene in two of six families but not in other candidate genes.
Munnes M; Fanaei S; Schmitz B; Muiznieks I; Holschneider AM; Doerfler W
Am J Med Genet; 2000 Sep; 94(1):19-27. PubMed ID: 10982477
[TBL] [Abstract][Full Text] [Related]
15. Exon structure and flanking intronic sequences of the human RET proto-oncogene.
Ceccherini I; Bocciardi R; Luo Y; Pasini B; Hofstra R; Takahashi M; Romeo G
Biochem Biophys Res Commun; 1993 Nov; 196(3):1288-95. PubMed ID: 7902707
[TBL] [Abstract][Full Text] [Related]
16. TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease.
Garcia-Barcelo M; Ganster RW; Lui VC; Leon TY; So MT; Lau AM; Fu M; Sham MH; Knight J; Zannini MS; Sham PC; Tam PK
Hum Mol Genet; 2005 Jan; 14(2):191-204. PubMed ID: 15548547
[TBL] [Abstract][Full Text] [Related]
17. Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus.
Edery P; Pelet A; Mulligan LM; Abel L; Attié T; Dow E; Bonneau D; David A; Flintoff W; Jan D
J Med Genet; 1994 Aug; 31(8):602-6. PubMed ID: 7815416
[TBL] [Abstract][Full Text] [Related]
18. Cloning and functional characterization of the chicken c-ros promoter.
Chen J; Tong J; Tanaka-Sukegawa I; Wang LH
Cell Growth Differ; 1995 Dec; 6(12):1523-30. PubMed ID: 9019157
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease.
Angrist M; Bolk S; Thiel B; Puffenberger EG; Hofstra RM; Buys CH; Cass DT; Chakravarti A
Hum Mol Genet; 1995 May; 4(5):821-30. PubMed ID: 7633441
[TBL] [Abstract][Full Text] [Related]
20. Polymerase chain reaction-single strand conformational polymorphism analysis of rearranged during transfection proto-oncogene in Chinese familial Hirschsprung's disease.
Guan T; Li JC; Li MJ; Tou JF
World J Gastroenterol; 2005 Jan; 11(2):275-9. PubMed ID: 15633231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
